ATE437630T1 - Vorrichtung und methode zur behandlung von urininkontinenz bei frauen - Google Patents

Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Info

Publication number
ATE437630T1
ATE437630T1 AT01918878T AT01918878T ATE437630T1 AT E437630 T1 ATE437630 T1 AT E437630T1 AT 01918878 T AT01918878 T AT 01918878T AT 01918878 T AT01918878 T AT 01918878T AT E437630 T1 ATE437630 T1 AT E437630T1
Authority
AT
Austria
Prior art keywords
ring
oxybutynin
women
urinary incontinence
treating urinary
Prior art date
Application number
AT01918878T
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Kay
Donald Koelmel
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE437630T1 publication Critical patent/ATE437630T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT01918878T 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen ATE437630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
ATE437630T1 true ATE437630T1 (de) 2009-08-15

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918878T ATE437630T1 (de) 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Country Status (12)

Country Link
US (2) US6436428B1 (de)
EP (2) EP2106785B1 (de)
JP (3) JP5265836B2 (de)
AT (1) ATE437630T1 (de)
AU (2) AU2001245901B2 (de)
BR (1) BR0109691A (de)
CA (1) CA2403475C (de)
DE (1) DE60139389D1 (de)
ES (1) ES2332262T3 (de)
IL (2) IL151858A0 (de)
MX (1) MXPA02009358A (de)
WO (1) WO2001070154A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
HUP0401438A3 (en) * 2001-08-31 2008-04-28 Schering Oy Drug delivery system
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
CN104257450B (zh) 2006-07-10 2017-05-10 第一次质量卫生公司 弹性装置
EP2104489A2 (de) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topische verabreichung von danazol
EP2170276B1 (de) * 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginale arzneiabgabevorrichtungen zur abgabe von makromolekülen und wasserlöslichen arzneimitteln
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
US20120053534A1 (en) * 2010-06-22 2012-03-01 Anu Mahashabde Intravaginal devices comprising anticholinergic agents, and methods of making thereof
MX2013002016A (es) * 2010-08-20 2013-03-25 Teva Womens Health Inc Dispositivos intravaginales, metodos de fabricacion y usos de los mismos.
CN103501764A (zh) * 2011-03-03 2014-01-08 阿勒根公司 基于硅酮的眼科制剂
JP2018509389A (ja) * 2015-01-30 2018-04-05 リ・ガリ・ベスローテン・フエンノートシャップＬｉ Ｇａｌｌｉ Ｂ．Ｖ． 膣用薬物送達デバイス
BR112020008231A2 (pt) 2017-10-27 2020-10-27 Renovia, Inc. dispositivos, sistemas e métodos para treinamento dos músculos do assoalho pélvico
CN119952301A (zh) * 2025-04-10 2025-05-09 中国核动力研究设计院 一种远距离激光切割头及其调焦方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
DE69326848T2 (de) 1992-05-13 2000-01-27 Alza Corp Oxybutynin zur transdermalen Verabreichung
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
ATE246909T1 (de) 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5674895A (en) 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
JP2001502302A (ja) 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
AU1256399A (en) 1998-10-07 2000-04-26 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
CA2573266C (en) * 2004-07-09 2011-11-08 The Population Council, Inc. Sustained release compositions containing progesterone receptor modulators

Also Published As

Publication number Publication date
ES2332262T3 (es) 2010-02-01
JP5265836B2 (ja) 2013-08-14
EP2106785A1 (de) 2009-10-07
WO2001070154A9 (en) 2001-12-20
BR0109691A (pt) 2003-06-10
AU4590101A (en) 2001-10-03
EP2106785B1 (de) 2016-12-07
US20020090390A1 (en) 2002-07-11
JP5675865B2 (ja) 2015-02-25
EP1278494A1 (de) 2003-01-29
IL151858A (en) 2009-12-24
CA2403475C (en) 2011-02-08
HK1053254A1 (en) 2003-10-17
IL151858A0 (en) 2003-04-10
JP5986149B2 (ja) 2016-09-06
CA2403475A1 (en) 2001-09-27
DE60139389D1 (de) 2009-09-10
WO2001070154A1 (en) 2001-09-27
JP2003527404A (ja) 2003-09-16
EP1278494A4 (de) 2005-11-02
JP2014210802A (ja) 2014-11-13
JP2013107895A (ja) 2013-06-06
MXPA02009358A (es) 2003-09-25
AU2001245901B2 (en) 2004-10-07
EP1278494B1 (de) 2009-07-29
US6436428B1 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
ATE437630T1 (de) Vorrichtung und methode zur behandlung von urininkontinenz bei frauen
NO20065380L (no) Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer.
CY1108296T1 (el) Σετ χειρουργικων εργαλειων για τη θεραπεια της γυναικειας ακρατειας ουρων
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DE60220858D1 (de) Intravaginalvorrichtung zur Verhinderung von weiblicher Harninkontinenz
JP2003527404A5 (de)
DE60141145D1 (de)
FR2836820B1 (fr) Dispositif chirurgical et bandelette pour le traitement de l'incontinence urinaire d'effort chez la femme
AR031721A1 (es) Un dispositivo para la incontinencia urinaria y un metodo para hacer el mismo
CA2497907A1 (en) C-shaped vaginal incontinence insert
DE69631674D1 (de) System oder gerät zur behandlung der ureter und/oder pyelo-ureter zusammenführung
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
CN101352360A (zh) 软弹带侧孔再造阴道模具
WO2001013780A3 (en) Apparatus and method for anesthetizing the cervical region of a female
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
WO2007018622A3 (en) Vaginal treatment composition
DK1150698T3 (da) Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion
DE60206888D1 (de) Harninkontinenzvorrichtung
NO20012569L (no) Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens
Chen Refinement of McIndoe's vaginal reconstruction with ORFIT “S” vaginal stent
UA31546A (uk) Спосіб деривації сечі після цистектомії
DE60027168D1 (de) Adrenomedullin zur behandlung von störungen des harnlassens
Toeplitz et al. RHINOSCLEROMA.
UA43128A (uk) Спосіб профілактики післяопераційних ускладнень рецидивних вентральних гриж
HAN et al. Follow-up Results Exceeding 3 Years of Anterior Vaginal Wall Sling Operation for Female Patients with Stress Urinary Incontinence

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties